# Middle East Pharmaceutical Industries Company

> Company on the TrustPlane Trade register, with its Wethaq rating and what it sells.

- Profile: https://raabet.io/en/companies/middle-east-pharmaceutical-industries-company-4016
- Arabic name: أفالون فارما
- Saudi Exchange: 4016 (Main Market (TASI))
- Sector: Pharma, Biotech & Life Sciences
- Legal form: Listed Joint Stock Company
- Website: https://www.avalonpharmaceutical.com
- City: Riyadh

## Wethaq rating

- Not yet sent to Wethaq

## About

Middle East Pharmaceutical Industries Company, branded as Avalon Pharma, is a Saudi pharmaceutical company that researches, develops, manufactures, and markets pharmaceutical and health/beauty products. Its website states it operates multiple manufacturing facilities in Riyadh, serves markets across Saudi Arabia, the MENA region and beyond, and had a portfolio of 300+ SKUs with 70+ brands and 40+ molecules in development. The company says it is headquartered in Riyadh and is listed on the Saudi Exchange (Tadawul) under ticker 4016.

## What they sell

- Tablets (Pharmaceutical products)
- Capsules (Pharmaceutical products)
- Nasal sprays (Pharmaceutical products)
- Creams (Topical medicines / cosmetics)
- Lotions (Topical medicines / cosmetics)
- Topical solutions (Topical medicines / cosmetics)
- Disinfectants / hand sanitizers (Hygiene products)
- Mouthwash (Hygiene products)
- Sunscreens (Dermocosmetics)
- Dietary supplements (Supplements)
- Generic prescription medicines (Pharmaceutical products)
- Private label manufacturing (Contract manufacturing)

## Sources

- https://www.avalonpharmaceutical.com/
- https://www.avalonpharmaceutical.com/about
- https://www.avalonpharmaceutical.com/manufacture
- https://www.avalonpharmaceutical.com/products
- https://www.avalonpharmaceutical.com/contact-us
- https://www.avalonpharmaceutical.com/ar/about
- https://www.avalonpharmaceutical.com/ar/manufacture
- https://www.avalonpharmaceutical.com/newsroom/73139f54343238b281000218/avalon-pharma-delivers-strong-h1-2026-performance-with-revenue-up-24-to-sar-267-mn-and-net-profit-increasing-26-to-sar-56-mn

- Last updated: 2026-09-19